Cynthia Owens

Cynthia is a compliance and ethics professional whose primary responsibility is defining the design and execution of the company’s clinical trial division with a focus on demonstrating medical device safety and efficacy. Her role is to safeguard trials are conducted in full compliance to GCP and all other applicable regulatory requirements in a global environment.

She is an expert in integrating integrity and compliance into healthcare and corporate processes to produce successful outcomes.

Cynthia has over 28 years of experience in the clinical trials, pharmaceutical, medical device, and healthcare industries. Her medical field experience began in 1989, focusing exclusively on clinical research from 1994-2005, then adding integrity monitoring and assessment of regulated industries, both small and large to her experience. In addition, she co-founded Asentral Institutional Review Board where their primary clients were medical device companies. Cynthia has served as Director of Clinical Trials for a variety of indications from diabetes to cardiovascular disease, representative clients include Astra Zeneca, Eli Lilly, GlaxoSmithKline, Novartis, and Pfizer. She has also served as Conflict Manager, overseeing conflicts of interest for a global public-private partnership focused on preclinical discovery and development.